_Enabled_Medical_Imaging_Market_Cover_Slide.png)
Artificial Intelligence (AI) Enabled Medical Imaging is the process of adoption of AI technology in the medical imaging to provide vast supply of medical case data and train its algorithms to find patterns in images, thus, enabling better treatment stratification in the population.
Global Artificial Intelligence (AI) Enabled Medical Imaging Market Analysis, 2021 research report depicts a deep-dive market analysis of statistics of Global Artificial Intelligence (AI) Enabled Medical Imaging market which consists of regional and country-wise market size, market forecast, CAGR market segmentation, market shares of diverse regions and countries, market share of various end users, applications, product type, technologies, competitive benchmarking, etc.
| Report Coverage | Details |
|---|---|
| Study Period | Historical Data: 2016-19 |
| Base Year: 2020 | |
| Forecast Period: 2021-26 | |
| CAGR (2021-2026) | 29% |
| Regions Covered | North America: The US, Canada, Mexico |
| Europe: Germany, France, UK, Italy, Sweden, Switzerland, Netherlands, Russia | |
| Asia-Pacific: China , Japan, South Korea, India, Singapore, Australia & New Zealand, Rest of Asia Pacific | |
| South America: Brazil, Rest of South America | |
| Middle East & Africa: GCC , Rest of Middle East & Afric | |
| Key Companies Profiled | Aidoc, Arterys Inc, Beijing Infervision Technology Co., Ltd., Blackford Analysis Limited, ContextVision AB, EnvoyAI, Fujifilm Holdings Corporation, General Electric Company, iCAD, Inc., Koninklijke Philips N.V., Mirada Medical Limited, NVIDIA Corporation, Nuance Communications, Inc, Resonance Health Ltd., Samsung Electronics Co., Ltd, Others. |
| Unit Denominations | USD Million/Billion |
Market Opportunities
According to MarkNtel Advisors’ research report titled “Global Artificial Intelligence (AI) Enabled Medical Imaging Market Analysis, 2021”, the Global Artificial Intelligence (AI) Enabled Medical Imaging market is anticipated to grow at a CAGR of around 29% during 2021-26F. The growth of the market is attributed to growing complexities of datasets fueling the requirement for AI, a boost in the number of medical imaging and radiology startups, and rising adoption of AI medical imaging in the healthcare industry with AI algorithms which analyzes data and helps doctors in screening, assessing, and diagnosing patients. Other major factors driving the market growth are the adoption of this technology by multiple pharmaceutical companies, bolstering investment by the hospitals in artificial intelligence for medical imaging, and increasing shortage of radiologists in many countries such as Mexico where there are only about 4,000 radiologists for 130 million people and Japan, where there are only 36 radiologists per million people. Hence, these are anticipated to augment the growth of the market in the forthcoming timeline.
Market Segmentation
Computed Tomography Acquired the Largest Market Share
Based on Modality, Computed Tomography acquired the largest market share in the Global artificial intelligence (AI) enabled medical imaging in 2021. The rising risk of developing cancer from such radiation exposure has surged the use of CT scans. Medical imaging engineers are attempting to create advancements that reduce the radiation dose from CT without compromising its diagnostic performance. Moreover, the increase prevalence of cancer globally will catalyze the market growth of the Artificial Intelligence (AI) Enabled Medical Imaging market globally in the near future as stated in the MarkNtel Advisors’ research report “Global Artificial Intelligence (AI) Enabled Medical Imaging Market Analysis, 2021”.
